Jim Cramer reviewed Cardinal Health, Inc. (NYSE:CAH) while breaking down 16 stocks for a market facing higher energy costs and economic uncertainty. During the episode, a caller sought Cramer’s opinion on the stock, and he said:

Alright, Jason Hollar is doing a great job. I got too enthusiastic about it. I’ll remonstrate on Friday. I got, I started buying it too soon for the trust. We bought some more today. I think it’s an amazing stock. It fell really hard. I do not think there’s anything wrong with Cardinal. If anything, I think it’s gotten better than when we spoke to Jason last time. So, I want you to buy it and buy it, get this, aggressively.

Photo by Artem Podrez on Pexels

Cardinal Health, Inc. (NYSE:CAH) supplies branded, generic, and specialty medicines and provides pharmacy and specialty drug services. The company also makes and distributes medical and surgical products and procedure kits. During the January 23 episode, a caller mentioned that they liked the stock and asked for Cramer’s opinion. He responded:

Oh, Jason Hollar. You know it’s funny… I’m out there. You got all these great drug companies, and who am I most blown away with? Hollar and Cardinal Health, and that urology purchase, the new purchase it just made. You’re dead right. CAH, I can see that stock going to $300.

While we acknowledge the potential of CAH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.